Abstract:Background: Odd-skipped related 1 (OSR1) has been reported as a tumor suppressor gene in various malignant tumors. The mechanism through which OSR1 regulates ovarian cancer (OC) progression remains unclear. Materials and methods: Immunohistochemistry was utilized to evaluate OSR1 expression in patients with ovarian cancer. We investigated the association between clinicopathological parameters and OSR1 expression in OC patients and the influence of OSR1 expression on patient survival and prognosis. OC cells with OSR1 overexpression or knockdown were established and validated using Western blot and Quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The influence of OSR1 on the NF-κB pathway was examined by analyzing the p-IκBα, IκBα, p65, and p-p65 protein expression. In vitro assays, such as cell cycle assay, Cell Counting Kit-8 (CCK-8), transwell invasion assay, wound healing migration assay, enzyme-linked immunoassay (ELISA), and Annexin V/PI flow cytometry apoptosis assay, were conducted to explore the effect of OSR1 knockdown or dual inhibition of OSR1 and the NF-κB pathway on OC malignant biological behavior. Results: OSR1 expression was downregulated in OC tissues, with significant associations observed between its expression and The International Federation of Gynecology and Obstetrics (FIGO) stage and tissue differentiation. Low OSR1 expression in OC patients correlated with reduced overall survival (OS) rates and poor prognosis. In vitro, experiments confirmed a negative correlation between OSR1 expression and NF-κB pathway activity. OSR1 knockdown facilitated OC cell malignant biological behavior, while the NF-κB pathway inhibitor (Bay 11-0782) reversed the impacts of OSR1 knockdown on cell proliferation, migration, invasion, and apoptosis. Conclusion: Our findings indicate that OSR1 is downregulated and associated with OC prognosis. OSR1 suppresses NF-κB pathway activity and inhibits OC progression by targeting the NF-κB pathway.

Knockdown of Aurora-B Alters Osteosarcoma Cell Malignant Phenotype Via Decreasing Phosphorylation of VCP and NF-κB Signaling

Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.

Potential Molecular Mechanisms of AURKB in the Oncogenesis and Progression of Osteosarcoma Cells: A Label-Free Quantitative Proteomics Analysis.

Aurora-B knockdown inhibits osteosarcoma metastasis by inducing autophagy via the mTOR/ULK1 pathway

Inhibition of Aurora-B Suppresses Osteosarcoma Cell Migration and Invasion

Silencing of Aurora Kinase A by RNA Interference Inhibits Tumor Growth in Human Osteosarcoma Cells by Inducing Apoptosis and G2/M Cell Cycle Arrest

Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.

Aurora-B Promotes Osteosarcoma Cell Growth and Metastasis Through Activation of the NPM1/ERK/NF-κβ/MMPs Axis.

Aurora-B Promotes Osteosarcoma Cell Growth and Metastasis Through Activation of the NPM1/ERK/NF-ʦ/MMPs Axis

Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma.

Aurora B Kinase As a Novel Molecular Approach for Osteosarcoma Therapy

Aurora Kinase-B Silencing Promotes Apoptosis of Osteosarcoma 143B Cells by ULK1 Phosphorylation-Induced Autophagy

Aurora-B: a Novel Biomarker in the Invasion and Metastasis of Osteosarcoma

Cyclovirobuxine D Inhibits the Growth of Osteosarcoma Cells Through the Induction of Autophagy Flux Arrest by Promoting Lysosomal Acidification

RNA Interference-Mediated Knockdown of Aurora-B Alters the Metastatic Behavior of A549 Cells Via Modulation of the Phosphoinositide 3-Kinase/akt Signaling Pathway

Inhibiting Valosin-Containing Protein Suppresses Osteosarcoma Cell Metastasis Via AKT/nuclear Factor of Kappa B Signaling Pathway in Vitro.

Expression of Aurora-B in Osteosarcoma and Its Relationship with Metastasis

OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer

Let-7g Reverses Malignant Phenotype of Osteosarcoma Cells by Targeting Aurora-B.

Aurora-A down-regulates IkappaBα via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival

Aurora-A Kinase: Potential Tumor Marker of Osteosarcoma